These results conformed closely to those reported in pancreatic cancer [15], esophageal cancer [14] and breast cancer [13], further providing evidence that IRF-2 overexpression might be associated with tumorigenesis of CRC. The gene discussed is IRF2; the disease is breast carcinoma.